This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Muriel Lize: Innovator in Antibody Research
Introduction
Muriel Lize is a prominent inventor based in Ingelheim am Rhein, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work has implications for various medical applications, showcasing her expertise and dedication to innovation.
Latest Patents
Muriel Lize holds a patent titled "Antibodies to Connective Tissue Growth Factor (CTGF) and Uses Thereof." This patent reflects her innovative approach to addressing challenges in medical science through the development of targeted therapies.
Career Highlights
Muriel is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role at the company has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to biotechnology.
Collaborations
Some of her notable coworkers include Andreas-David Brunner and Lars Dittus. Their collaborative efforts have fostered an environment of innovation and research excellence.
Conclusion
Muriel Lize's work in antibody research exemplifies the impact of innovation in biotechnology. Her contributions continue to advance the field and inspire future developments in medical science.